Literature DB >> 2430442

Limitations and advantages of the ejection fraction for defining high risk after acute myocardial infarction.

S Ahnve, E Gilpin, H Henning, G Curtis, D Collins, J Ross.   

Abstract

Left ventricular (LV) ejection fraction (EF) is known to be related to prognosis after acute myocardial infarction (AMI), but its role alone and in combination with other factors in the definition of a high-risk group has not been adequately specified. Several recent multicenter studies emphasize that LVEF together with features of ventricular ectopic activity during ambulatory electrocardiography define a group at high risk for death for up to 3 years. However, these high-risk groups comprised only a small fraction of the population (less than 7.5%) and failed to include 75% or more (less than 25% specificity) of observed events. In our study, LVEF was determined close to the time of hospital discharge in 750 patients with AMI enrolled in a collaborative study. Used alone, an LVEF of less than 0.45 best defined a high-risk group (39% of the population) yielding 62% sensitivity and 64% specificity for total cardiac mortality by 1 year; it was 77% sensitive for sudden death alone. In a multivariate analysis together with other factors, LVEF was an independent predictor, but other markers of LV dysfunction entered before LVEF with similar sensitivity for total cardiac deaths, but with increased specificity (75%). When an LVEF of less than 0.45 was used together with the presence of complex arrhythmias to define a high-risk group (19% of the population), sensitivity decreased to 39% and specificity increased to 84%. Thus, LVEF is a simple and effective alternative to multivariate analysis for risk assessment after AMI.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 2430442     DOI: 10.1016/s0002-9149(86)80002-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

1.  beta blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study.

Authors:  K S Spargias; A S Hall; D C Greenwood; S G Ball
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

2.  Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial.

Authors:  Vladimír Dzavík; Christopher E Buller; Gervasio A Lamas; James M Rankin; G B John Mancini; Warren J Cantor; Ronald J Carere; John R Ross; Deborah Atchison; Sandra Forman; Boban Thomas; Pawel Buszman; Carlos Vozzi; Anthony Glanz; Eric A Cohen; Peter Meciar; Gerald Devlin; Alice Mascette; George Sopko; Genell L Knatterud; Judith S Hochman
Journal:  Circulation       Date:  2006-11-14       Impact factor: 29.690

Review 3.  Prognostic assessment in coronary artery disease: role of radionuclide angiography.

Authors:  R O Bonow
Journal:  J Nucl Cardiol       Date:  1994 May-Jun       Impact factor: 5.952

Review 4.  Beyond ejection fraction.

Authors:  A Marmor; D Jain; B Zaret
Journal:  J Nucl Cardiol       Date:  1994 Sep-Oct       Impact factor: 5.952

5.  Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.

Authors:  Malini Madhavan; Jonathan W Waks; Paul A Friedman; Daniel B Kramer; Alfred E Buxton; Peter A Noseworthy; Ramila A Mehta; David O Hodge; Angela Y Higgins; Tracy L Webster; Chance M Witt; Yong-Mei Cha; Bernard J Gersh
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-03

Review 6.  Should angiotensin converting enzyme (ACE) inhibitors be used routinely after infarction? Perspectives from the Survival and Ventricular Enlargement (SAVE) trial.

Authors:  M S Sutton
Journal:  Br Heart J       Date:  1994-02

7.  Regional functional recovery after acute myocardial infarction: a cardiac magnetic resonance long-term study.

Authors:  Agnes Mayr; Kathrin Pedarnig; Gert Klug; Michael Schocke; Otmar Pachinger; Werner Jaschke; Bernhard Metzler
Journal:  Int J Cardiovasc Imaging       Date:  2011-10-01       Impact factor: 2.357

Review 8.  Can we predict sudden cardiac death?

Authors:  T Meinertz; T Hofmann; M Zehender
Journal:  Drugs       Date:  1991       Impact factor: 9.546

9.  Exercise training preserves vagal preganglionic neurones and restores parasympathetic tonus in heart failure.

Authors:  Marcelo H A Ichige; Carla R Santos; Camila P Jordão; Alexandre Ceroni; Carlos E Negrão; Lisete C Michelini
Journal:  J Physiol       Date:  2016-08-29       Impact factor: 5.182

10.  Prognostic value of coronary angiography in patients with chronic ischemic left ventricular dysfunction and evidence of viable myocardium on thallium reinjection imaging.

Authors:  M Petretta; A Cuocolo; D Bonaduce; E Nicolai; M L Vicario; M Salvatore
Journal:  J Nucl Cardiol       Date:  1997 Sep-Oct       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.